Biotech
Aug. 28, 2013
Firms vie for biotechs amid IPO boom
IPOs in the life sciences sector have skyrocketed, spurring increased competition among law firms trying to nab startup companies looking for representation.
Daily Journal Staff Writer
A biotech startup represented by Latham & Watkins LLP is gearing up to go public in November after months of consultation and planning with the Los Angeles-based global law firm, known for its familiarity with companies in the life sciences arena.
The company, which has yet to formally announce its planned public offering, was previously represented by a well known New York firm. But in i...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In